Cardiovascular effects of 1,5-benzothiazepine derivatives having a l- cis and d-cis configuration in anesthetized dogs

Biological and Pharmaceutical Bulletin

Volumn 21, Issue 1, 1998, Pages 50-55

  Kaburaki, Minako ^a   Inoue, Hirotaka ^a   Doi, Hisayoshi ^a   Yasuhara, Mikiko ^a   Narita, Hiroshi ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

1,5 benzothiazepine derivative; Cardiovascular effect; Diltiazem; Optical isomer; TA 993

Indexed keywords

3 ACETOXY 5 [2 (DIMETHYLAMINO)ETHYL] 2,3 DIHYDRO 8 METHYL 2 (4 METHYLPHENYL) 1,5 BENZOTHIAZEPIN 4(5H) ONE MALEATE; BENZOTHIAZEPINE DERIVATIVE; DILTIAZEM; POTASSIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM ANTAGONISM; CARDIOVASCULAR RESPONSE; CAROTID ARTERY FLOW; CIS ISOMER; DEPOLARIZATION; DOG; DRUG STRUCTURE; FEMALE; FEMORAL ARTERY; INTRAVENOUS DRUG ADMINISTRATION; LIMB BLOOD FLOW; MALE; NONHUMAN; POTASSIUM TRANSPORT; THROMBOCYTE AGGREGATION;

EID: 0031934379     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.21.50     Document Type: Article

References (20)

1. Klein W., Brandt D., Vrecko K., Härringer M., Circ. Res., 52, 174- 181 (1983).
2. Rosenthal S. J., Lamb I.H., Schroeder J. S., Ginsburg R., Circ. Res., 52, 153-157 (1983).
3. Safar M. E., Simon A. Ch., Levenson J. A., Cazor J. L., Circ. Res., 52, 169-173 (1983).
4. Yasue H., Omote S., Takizawa A., Nagao, M., Circ. Res., 52, 147- 152 (1983).
5. Sato M., Nagao T., Yamaguchi I., Nakajima H., Kiyomoto A., Arzneim.-Forsch/Drug Res., 21, 1338-1343 (1971).
6. Nagao T., Ikeo T., Sato M., Jpn. J. Pharmacol., 27, 330-332 (1977).
7. Ito Y., Kuriyama H., Suzuki H., Br. J. Pharmacol., 64, 503-510 (1978).
8. Fujiwara S., Ito Y., Itoh T., Kuriyama H., Suzuki H., Br. J. Pharmacol., 75, 455-467(1982).
9. Kikkawa K., Murata S., Nagao T., Arzneim.-Forsch./Drug Res., 38, 526-531 (1988).
10. Murata S., Kikkawa K., Yabana H., Nagao T., Arzneim. -Forsch./Drug Res., 38, 521-525 (1988).
11. Nagao T., Sato M., Nakajima H., Jpn. J. Pharmacol., 22, 1-10 (1972).
12. Nagao T., Sato M., Nakajima H., Kiyomoto A., Chem. Pharm. Bull., 21, 92-97 (1973).
13. Tanaka T., Inoue H., Date T., Okamura K., Aoe K., Takeda M., Kugita H., Murata S., Yamaguchi T., Kikkawa K., Nakajima S., Nagao T., Chem. Pharm. Bull., 40, 1476-1480 (1992).
14. Inoue H., Konda M., Hashiyama T., Otsuka H., Takahashi K., Gaino M., Date T., Aoe K., Takeda M., Murata S., Narita H., Nagao T., J. Med. Chem., 34, 675-687 (1991).
15. Kaburaki M., Narita H., Yabana H., Karasawa T., Doi H., Murata S., J. Cardiovasc. Pharmacol., 31, (1998), in press.
16. Odawara A., Kikkawa K., Katoh M., Toryu H., Shimazaki T., Sasaki Y., Circ. Res., 78, 643-649 (1996).
17. Arunlakshana O., Shild H. O., Br. J. Pharmacol., 14, 48-58 (1959).
18. Nasa Y., Ichihara K., Abiko Y., J. Pharmacol. Exp. Ther., 255, 680- 689 (1990).
19. Stern J. H., Kaupp U. B., MacLeish P. R., Proc. Natl. Acad. Sci. U.S.A., 83, 1163-1167 (1986).
20. Kiyomoto A., Sasaki Y., Odawara A., Morita T., Circ. Res., 52, 115- 119 (1983).